Fri, Jul 25, 2014, 6:19 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Arena Pharmaceuticals, Inc. Message Board

  • zilanewswatch zilanewswatch Apr 28, 2013 3:35 AM Flag

    CHMP, which is Europe's equivalent of the Food and Drug Administration's advisory panel

    The end of the week brought fantastic news for shareholders in Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) who witnessed the CHMP recommending approval for Nuedexta, it's already U.S.-approved treatment for psuedobulbar affect. An approval in Europe would be a key win for Avanir as Nuedexta currently makes up the majority of its revenue. In addition, it's worth noting that the European Medicine Agency's panel recommended two dosing regimens, potentially broadening in patient reach. Shares reacted notably higher but tapered off by the end of the day on Friday. Although the EMA isn't required to follow the recommendation of its panel, this would be a case where I'd be mildly surprised if it didn't.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ARNA
4.77-0.08(-1.65%)Jul 25 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.